Realco
Andardmount
Rebaudioside A 97%
REBAUDIOSIDE A, [CAS 58543-16-1] is the more potent and most pleasant tasting ..more
  Home Cosmetic Peptides
Anard mount
  hormones intermediates
Anard mount
  bio-chemistry Technical News
Anard mount
  chemotherapeutics prostaglandins
Anard mount
  phyto chemicals news & products
Anard mount
  regulatory dossiers latest developments
  Pharmaceutical Peptides contact us
Anard mount
dot
 
dot
Anard mount METHOTREXATE
Anard mount Anard mount




METHOTREXATE, [CAS 59-05-2] used in the treatment of auto-immune diseases; its action is the inhibition of folic acid metabolism. Originally used to treat a wide variety of cancers, it remains pivotal where many neoplastic conditions are concerned including lymphoblastic leukaemia.

Following the establishment of the first cancer research centre in the USA, as early as 1953 the FDA (Food & Drug Administration) gave its approval to Methotrexate for use as an oncology drug. Methotrexate is generally used – frequently in combination with Misoprostol (also available from Andard-Mount) – as an abortifacient as well as in the treatment of ectopic pregnancies; other diseases where this product continues to have an  important role includes psoriasis, rheumatoid arthritis, polymyositis, scleroderma and Crohn’s disease.

Supplied with the full support of the Andard-Mount well known and appreciated continuity for technical and commercial co-operation, Methotrexate meets the requirements of current pharmacopoeias.

 
2007-2009 © Andard-Mount Company Ltd. All rights reserved.